Laparoscopic and thoracoscopic approaches for the treatment of hepatocellular carcinoma

被引：47

作者：

Teramoto, K ^{[1
]}

Kawamura, T ^{[1
]}

Takamatsu, S ^{[1
]}

Nakamura, N ^{[1
]}

Kudo, A ^{[1
]}

Noguchi, N ^{[1
]}

Irie, T ^{[1
]}

Arii, S ^{[1
]}

机构：

[1] Tokyo Med & Dent Univ, Div Hepatol Biliary Pancreat Surg, Dept Surg, Bunkyo Ku, Tokyo 1138519, Japan

来源：

AMERICAN JOURNAL OF SURGERY | 2005年 / 189卷 / 04期

关键词：

laparoscopy; thoracoscopy; liver resection; hepatocellular carcinoma; ablation therapy;

D O I：

10.1016/j.amjsurg.2004.09.018

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Background: Laparoscopic/thoracoscopic intervention has been recently developed for hepatocellular carcinoma (HCC). However, no precise evaluation. regarding this type of surgery has been performed. Patients and Methods: A total of 33 laparoscopic and thoracoscopic treatments were performed on HCC patients, laparoscopic or thoracoscopic liver resection (LTR) in 15 patients and laparoscopic or thoracoscopic thermal ablation (LTA) in 18 patients. Results: Postoperative hospital stay was 12.7 days after resection and 14.8 days after ablation. The 1- and 3- year actuarial survival rate, were 100% and 80%, respectively, after LTR and 95% and 75%, respectively, after LTA. The 1- and 3- year disease-free survival rates were 75% and 40%, respectively, after LTR, and 60% and 28%, respectively, after LTA. Conclusion: LTR has the advantages of the curability of open surgery and less invasiveness of laparoscopic surgery. LTA is useful for tumors that cannot be percutaneously detected by ultrasound. Laparoscopic/thoracoscopic intervention is therefore considered an alternative means of treatment for selected HCC patients. (c) 2005 Excerpta Medica Inc. All rights reserved.

引用

页码：474 / 478

页数：5

共 17 条

[11]

Montorsi M, 2001, HEPATO-GASTROENTEROL, V48, P41

[12]

Podnos YD, 2001, AM SURGEON, V67, P1181

[13] Locoregional therapies for hepatocellular carcinoma: A critical review from the surgeon's perspective [J].